Cytomegalovirus retinitis: pathogenesis and treatment options.
BACKGROUND
While patients infected with the human immunodeficiency virus (HIV) are displaying less cytomegalovirus (CMV) retinitis as a result of the use of a combination of anti-HIV medications, it still remains a serious threat to vision in this population.


METHODS
This review examines the nature of CMV infection, in general, and discusses the pathogenesis, clinical features, and treatment options for CMV retinitis, in particular.
Koevary
S B
SB
Ocular Research Center, New England College of Optometry, Boston, Massachusetts.
D017088:AIDS-Related Opportunistic Infections / Q000175:diagnosis / Q000188:drug therapy / Q000821:virology; D000998:Antiviral Agents / Q000627:therapeutic use*; D003587:Cytomegalovirus / Q000235:genetics; D017726:Cytomegalovirus Retinitis / Q000175:diagnosis / Q000188:drug therapy / Q000821:virology; D004279:DNA, Viral / Q000032:analysis; D003937:Diagnosis, Differential; D006678:HIV; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D011379:Prognosis
D000998:Antiviral Agents; D004279:DNA, Viral; D007166:Immunosuppressive Agents